Global General Anesthesia Drugs Market Growth 2020-2025

  • receipt Report ID : 140057
  • calendar_today Published On: Nov, 2020
  • file_copy Pages: 167
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this study, over the next five years the General Anesthesia Drugs market will register a 2.8%% CAGR in terms of revenue, the global market size will reach $ 7514.3 million by 2025, from $ 6728.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in General Anesthesia Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of General Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the General Anesthesia Drugs, covering the supply chain analysis, impact assessment to the General Anesthesia Drugs market size growth rate in several scenarios, and the measures to be undertaken by General Anesthesia Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Propofol

Etomidate

Midazolam

Sevoflurane

Isoflurane

Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Intravenous Anesthetics

Inhalational Anesthetics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Astrazeneca

Nhwa

Fresenius-Kabi

Baxter Healthcare

B.Braun

AbbVie

Hikma Pharmaceuticals

Maruishi

Mylan

Piramal

Hengrui

Lunan

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global General Anesthesia Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of General Anesthesia Drugs market by identifying its various subsegments.

Focuses on the key global General Anesthesia Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the General Anesthesia Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of General Anesthesia Drugs submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global General Anesthesia Drugs Consumption 2015-2025

2.1.2 General Anesthesia Drugs Consumption CAGR by Region

2.2 General Anesthesia Drugs Segment by Type

2.2.1 Propofol

2.2.2 Etomidate

2.2.3 Midazolam

2.2.4 Sevoflurane

2.2.5 Isoflurane

2.2.6 Others

2.3 General Anesthesia Drugs Consumption by Type

2.3.1 Global General Anesthesia Drugs Consumption Market Share by Type (2015-2020)

2.3.2 Global General Anesthesia Drugs Revenue and Market Share by Type (2015-2020)

2.3.3 Global General Anesthesia Drugs Sale Price by Type (2015-2020)

2.4 General Anesthesia Drugs Segment by Application

2.4.1 Intravenous Anesthetics

2.4.2 Inhalational Anesthetics

2.5 General Anesthesia Drugs Consumption by Application

2.5.1 Global General Anesthesia Drugs Consumption Market Share by Type (2015-2020)

2.5.2 Global General Anesthesia Drugs Value and Market Share by Type (2015-2020)

2.5.3 Global General Anesthesia Drugs Sale Price by Type (2015-2020)

3 Global General Anesthesia Drugs by Company

3.1 Global General Anesthesia Drugs Sales Market Share by Company

3.1.1 Global General Anesthesia Drugs Sales by Company (2018-2020)

3.1.2 Global General Anesthesia Drugs Sales Market Share by Company (2018-2020)

3.2 Global General Anesthesia Drugs Revenue Market Share by Company

3.2.1 Global General Anesthesia Drugs Revenue by Company (2018-2020)

3.2.2 Global General Anesthesia Drugs Revenue Market Share by Company (2018-2020)

3.3 Global General Anesthesia Drugs Sale Price by Company

3.4 Global General Anesthesia Drugs Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global General Anesthesia Drugs Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players General Anesthesia Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 General Anesthesia Drugs by Regions

4.1 General Anesthesia Drugs by Regions

4.2 Americas General Anesthesia Drugs Consumption Growth

4.3 APAC General Anesthesia Drugs Consumption Growth

4.4 Europe General Anesthesia Drugs Consumption Growth

4.5 Middle East & Africa General Anesthesia Drugs Consumption Growth

5 Americas

5.1 Americas General Anesthesia Drugs Consumption by Countries

5.1.1 Americas General Anesthesia Drugs Consumption by Countries (2015-2020)

5.1.2 Americas General Anesthesia Drugs Value by Countries (2015-2020)

5.2 Americas General Anesthesia Drugs Consumption by Type

5.3 Americas General Anesthesia Drugs Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC General Anesthesia Drugs Consumption by Regions

6.1.1 APAC General Anesthesia Drugs Consumption by Regions (2015-2020)

6.1.2 APAC General Anesthesia Drugs Value by Regions (2015-2020)

6.2 APAC General Anesthesia Drugs Consumption by Type

6.3 APAC General Anesthesia Drugs Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe General Anesthesia Drugs by Countries

7.1.1 Europe General Anesthesia Drugs Consumption by Countries (2015-2020)

7.1.2 Europe General Anesthesia Drugs Value by Countries (2015-2020)

7.2 Europe General Anesthesia Drugs Consumption by Type

7.3 Europe General Anesthesia Drugs Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa General Anesthesia Drugs by Countries

8.1.1 Middle East & Africa General Anesthesia Drugs Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa General Anesthesia Drugs Value by Countries (2015-2020)

8.2 Middle East & Africa General Anesthesia Drugs Consumption by Type

8.3 Middle East & Africa General Anesthesia Drugs Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 General Anesthesia Drugs Distributors

10.3 General Anesthesia Drugs Customer

11 Global General Anesthesia Drugs Market Forecast

11.1 Global General Anesthesia Drugs Consumption Forecast (2021-2025)

11.2 Global General Anesthesia Drugs Forecast by Regions

11.2.1 Global General Anesthesia Drugs Forecast by Regions (2021-2025)

11.2.2 Global General Anesthesia Drugs Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global General Anesthesia Drugs Forecast by Type

11.8 Global General Anesthesia Drugs Forecast by Application

12 Key Players Analysis

12.1 Astrazeneca

12.1.1 Company Information

12.1.2 General Anesthesia Drugs Product Offered

12.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Astrazeneca Latest Developments

12.2 Nhwa

12.2.1 Company Information

12.2.2 General Anesthesia Drugs Product Offered

12.2.3 Nhwa General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Nhwa Latest Developments

12.3 Fresenius-Kabi

12.3.1 Company Information

12.3.2 General Anesthesia Drugs Product Offered

12.3.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Fresenius-Kabi Latest Developments

12.4 Baxter Healthcare

12.4.1 Company Information

12.4.2 General Anesthesia Drugs Product Offered

12.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Baxter Healthcare Latest Developments

12.5 B.Braun

12.5.1 Company Information

12.5.2 General Anesthesia Drugs Product Offered

12.5.3 B.Braun General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 B.Braun Latest Developments

12.6 AbbVie

12.6.1 Company Information

12.6.2 General Anesthesia Drugs Product Offered

12.6.3 AbbVie General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 AbbVie Latest Developments

12.7 Hikma Pharmaceuticals

12.7.1 Company Information

12.7.2 General Anesthesia Drugs Product Offered

12.7.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Hikma Pharmaceuticals Latest Developments

12.8 Maruishi

12.8.1 Company Information

12.8.2 General Anesthesia Drugs Product Offered

12.8.3 Maruishi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Maruishi Latest Developments

12.9 Mylan

12.9.1 Company Information

12.9.2 General Anesthesia Drugs Product Offered

12.9.3 Mylan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Mylan Latest Developments

12.10 Piramal

12.10.1 Company Information

12.10.2 General Anesthesia Drugs Product Offered

12.10.3 Piramal General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Piramal Latest Developments

12.11 Hengrui

12.11.1 Company Information

12.11.2 General Anesthesia Drugs Product Offered

12.11.3 Hengrui General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 Hengrui Latest Developments

12.12 Lunan

12.12.1 Company Information

12.12.2 General Anesthesia Drugs Product Offered

12.12.3 Lunan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 Lunan Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. General Anesthesia Drugs Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Propofol

Table 5. Major Players of Etomidate

Table 6. Major Players of Midazolam

Table 7. Major Players of Sevoflurane

Table 8. Major Players of Isoflurane

Table 9. Major Players of Others

Table 10. Global Consumption Sales by Type (2015-2020)

Table 11. Global General Anesthesia Drugs Consumption Market Share by Type (2015-2020)

Table 12. Global General Anesthesia Drugs Revenue by Type (2015-2020) ($ million)

Table 13. Global General Anesthesia Drugs Value Market Share by Type (2015-2020) ($ Millions)

Table 14. Global General Anesthesia Drugs Sale Price by Type (2015-2020)

Table 15. Global Consumption Sales by Application (2015-2020)

Table 16. Global General Anesthesia Drugs Consumption Market Share by Application (2015-2020)

Table 17. Global General Anesthesia Drugs Value by Application (2015-2020)

Table 18. Global General Anesthesia Drugs Value Market Share by Application (2015-2020)

Table 19. Global General Anesthesia Drugs Sale Price by Application (2015-2020)

Table 20. Global General Anesthesia Drugs Sales by Company (2017-2019) (K L)

Table 21. Global General Anesthesia Drugs Sales Market Share by Company (2017-2019)

Table 22. Global General Anesthesia Drugs Revenue by Company (2017-2019) ($ Millions)

Table 23. Global General Anesthesia Drugs Revenue Market Share by Company (2017-2019)

Table 24. Global General Anesthesia Drugs Sale Price by Company (2017-2019)

Table 25. Global General Anesthesia Drugs Manufacturing Base Distribution and Sales Area by Manufacturers

Table 26. Players General Anesthesia Drugs Products Offered

Table 27. General Anesthesia Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 28. Global General Anesthesia Drugs Consumption by Regions 2015-2020 (K L)

Table 29. Global General Anesthesia Drugs Consumption Market Share by Regions 2015-2020

Table 30. Global General Anesthesia Drugs Value by Regions 2015-2020 ($ Millions)

Table 31. Global General Anesthesia Drugs Value Market Share by Regions 2015-2020

Table 32. Americas General Anesthesia Drugs Consumption by Countries (2015-2020) (K L)

Table 33. Americas General Anesthesia Drugs Consumption Market Share by Countries (2015-2020)

Table 34. Americas General Anesthesia Drugs Value by Countries (2015-2020) ($ Millions)

Table 35. Americas General Anesthesia Drugs Value Market Share by Countries (2015-2020)

Table 36. Americas General Anesthesia Drugs Consumption by Type (2015-2020) (K L)

Table 37. Americas General Anesthesia Drugs Consumption Market Share by Type (2015-2020)

Table 38. Americas General Anesthesia Drugs Consumption by Application (2015-2020) (K L)

Table 39. Americas General Anesthesia Drugs Consumption Market Share by Application (2015-2020)

Table 40. APAC General Anesthesia Drugs Consumption by Countries (2015-2020) (K L)

Table 41. APAC General Anesthesia Drugs Consumption Market Share by Countries (2015-2020)

Table 42. APAC General Anesthesia Drugs Value by Regions (2015-2020) ($ Millions)

Table 43. APAC General Anesthesia Drugs Value Market Share by Regions (2015-2020)

Table 44. APAC General Anesthesia Drugs Consumption by Type (2015-2020) (K L)

Table 45. APAC General Anesthesia Drugs Consumption Market Share by Type (2015-2020)

Table 46. APAC General Anesthesia Drugs Consumption by Application (2015-2020) (K L)

Table 47. APAC General Anesthesia Drugs Consumption Market Share by Application (2015-2020)

Table 48. Europe General Anesthesia Drugs Consumption by Countries (2015-2020) (K L)

Table 49. Europe General Anesthesia Drugs Consumption Market Share by Countries (2015-2020)

Table 50. Europe General Anesthesia Drugs Value by Countries (2015-2020) ($ Millions)

Table 51. Europe General Anesthesia Drugs Value Market Share by Countries (2015-2020)

Table 52. Europe General Anesthesia Drugs Consumption by Type (2015-2020) (K L)

Table 53. Europe General Anesthesia Drugs Consumption Market Share by Type (2015-2020)

Table 54. Europe General Anesthesia Drugs Consumption by Application (2015-2020) (K L)

Table 55. Europe General Anesthesia Drugs Consumption Market Share by Application (2015-2020)

Table 56. Middle East & Africa General Anesthesia Drugs Consumption by Countries (2015-2020) (K L)

Table 57. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Countries (2015-2020)

Table 58. Middle East & Africa General Anesthesia Drugs Value by Countries (2015-2020) ($ Millions)

Table 59. Middle East & Africa General Anesthesia Drugs Value Market Share by Countries (2015-2020)

Table 60. Middle East & Africa General Anesthesia Drugs Consumption by Type (2015-2020) (K L)

Table 61. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Type (2015-2020)

Table 62. Middle East & Africa General Anesthesia Drugs Consumption by Application (2015-2020) (K L)

Table 63. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Application (2015-2020)

Table 64. General Anesthesia Drugs Distributors List

Table 65. General Anesthesia Drugs Customer List

Table 66. Global General Anesthesia Drugs Consumption Forecast by Countries (2021-2025) (K L)

Table 67. Global General Anesthesia Drugs Consumption Market Forecast by Regions

Table 68. Global General Anesthesia Drugs Value Forecast by Countries (2021-2025) ($ Millions)

Table 69. Global General Anesthesia Drugs Value Market Share Forecast by Regions

Table 70. Global General Anesthesia Drugs Consumption Forecast by Type (2021-2025) (K L)

Table 71. Global General Anesthesia Drugs Consumption Market Share Forecast by Type (2021-2025)

Table 72. Global General Anesthesia Drugs Value Forecast by Type (2021-2025) ($ Millions)

Table 73. Global General Anesthesia Drugs Value Market Share Forecast by Type (2021-2025)

Table 74. Global General Anesthesia Drugs Consumption Forecast by Application (2021-2025) (K L)

Table 75. Global General Anesthesia Drugs Consumption Market Share Forecast by Application (2021-2025)

Table 76. Global General Anesthesia Drugs Value Forecast by Application (2021-2025) ($ Millions)

Table 77. Global General Anesthesia Drugs Value Market Share Forecast by Application (2021-2025)

Table 78. Astrazeneca Product Offered

Table 79. Astrazeneca General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 80. Astrazeneca Main Business

Table 81. Astrazeneca Latest Developments

Table 82. Astrazeneca Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors

Table 83. Nhwa Product Offered

Table 84. Nhwa General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 85. Nhwa Main Business

Table 86. Nhwa Latest Developments

Table 87. Nhwa Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors

Table 88. Fresenius-Kabi Product Offered

Table 89. Fresenius-Kabi General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 90. Fresenius-Kabi Main Business

Table 91. Fresenius-Kabi Latest Developments

Table 92. Fresenius-Kabi Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Baxter Healthcare Product Offered

Table 94. Baxter Healthcare General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 95. Baxter Healthcare Main Business

Table 96. Baxter Healthcare Latest Developments

Table 97. Baxter Healthcare Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. B.Braun Product Offered

Table 99. B.Braun General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 100. B.Braun Main Business

Table 101. B.Braun Latest Developments

Table 102. B.Braun Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. AbbVie Product Offered

Table 104. AbbVie General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 105. AbbVie Main Business

Table 106. AbbVie Latest Developments

Table 107. AbbVie Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Hikma Pharmaceuticals Product Offered

Table 109. Hikma Pharmaceuticals Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Hikma Pharmaceuticals Main Business

Table 111. Hikma Pharmaceuticals Latest Developments

Table 112. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 113. Maruishi Product Offered

Table 114. Maruishi General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 115. Maruishi Main Business

Table 116. Maruishi Latest Developments

Table 117. Maruishi Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Mylan Product Offered

Table 119. Mylan General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 120. Mylan Main Business

Table 121. Mylan Latest Developments

Table 122. Mylan Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. Piramal Product Offered

Table 124. Piramal General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 125. Piramal Main Business

Table 126. Piramal Latest Developments

Table 127. Piramal Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Hengrui Product Offered

Table 129. Hengrui General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 130. Hengrui Main Business

Table 131. Hengrui Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 132. Hengrui Latest Developments

Table 133. Lunan Product Offered

Table 134. Lunan General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 135. Lunan Main Business

Table 136. Lunan Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 137. Lunan Latest Developments

List of Figures

Figure 1. Picture of General Anesthesia Drugs

Figure 2. General Anesthesia Drugs Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global General Anesthesia Drugs Consumption Growth Rate 2015-2025 (K L)

Figure 5. Global General Anesthesia Drugs Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Propofol

Figure 7. Product Picture of Etomidate

Figure 8. Product Picture of Midazolam

Figure 9. Product Picture of Sevoflurane

Figure 10. Product Picture of Isoflurane

Figure 11. Product Picture of Others

Figure 12. Global General Anesthesia Drugs Consumption Market Share by Type (2015-2020)

Figure 13. Global General Anesthesia Drugs Value Market Share by Type (2015-2020)

Figure 14. General Anesthesia Drugs Consumed in Intravenous Anesthetics

Figure 15. Global General Anesthesia Drugs Market: Intravenous Anesthetics (2015-2020) (K L)

Figure 16. Global General Anesthesia Drugs Market: Intravenous Anesthetics (2015-2020) ($ Millions)

Figure 17. General Anesthesia Drugs Consumed in Inhalational Anesthetics

Figure 18. Global General Anesthesia Drugs Market: Inhalational Anesthetics (2015-2020) (K L)

Figure 19. Global General Anesthesia Drugs Market: Inhalational Anesthetics (2015-2020) ($ Millions)

Figure 20. Global General Anesthesia Drugs Consumption Market Share by Application (2015-2020)

Figure 21. Global General Anesthesia Drugs Value Market Share by Application (2015-2020)

Figure 22. Global General Anesthesia Drugs Sales Market Share by Company in 2017

Figure 23. Global General Anesthesia Drugs Sales Market Share by Company in 2019

Figure 24. Global General Anesthesia Drugs Revenue Market Share by Company in 2017

Figure 25. Global General Anesthesia Drugs Revenue Market Share by Company in 2019

Figure 26. Global General Anesthesia Drugs Sale Price by Company in 2019

Figure 27. Global General Anesthesia Drugs Consumption Market Share by Regions 2015-2020

Figure 28. Global General Anesthesia Drugs Value Market Share by Regions 2015-2020

Figure 29. Americas General Anesthesia Drugs Consumption 2015-2020 (K L)

Figure 30. Americas General Anesthesia Drugs Value 2015-2020 ($ Millions)

Figure 31. APAC General Anesthesia Drugs Consumption 2015-2020 (K L)

Figure 32. APAC General Anesthesia Drugs Value 2015-2020 ($ Millions)

Figure 33. Europe General Anesthesia Drugs Consumption 2015-2020 (K L)

Figure 34. Europe General Anesthesia Drugs Value 2015-2020 ($ Millions)

Figure 35. Middle East & Africa General Anesthesia Drugs Consumption 2015-2020 (K L)

Figure 36. Middle East & Africa General Anesthesia Drugs Value 2015-2020 ($ Millions)

Figure 37. Americas General Anesthesia Drugs Consumption Market Share by Countries in 2019

Figure 38. Americas General Anesthesia Drugs Value Market Share by Countries in 2019

Figure 39. Americas General Anesthesia Drugs Consumption Market Share by Type in 2019

Figure 40. Americas General Anesthesia Drugs Consumption Market Share by Application in 2019

Figure 41. United States General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 42. United States General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 43. Canada General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 44. Canada General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 45. Mexico General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 46. Mexico General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 47. APAC General Anesthesia Drugs Consumption Market Share by Countries in 2019

Figure 48. APAC General Anesthesia Drugs Value Market Share by Regions in 2019

Figure 49. APAC General Anesthesia Drugs Consumption Market Share by Type in 2019

Figure 50. APAC General Anesthesia Drugs Consumption Market Share by Application in 2019

Figure 51. China General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 52. China General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 53. Japan General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 54. Japan General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 55. Korea General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 56. Korea General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 57. Southeast Asia General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 58. Southeast Asia General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 59. India General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 60. India General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 61. Australia General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 62. Australia General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 63. Europe General Anesthesia Drugs Consumption Market Share by Countries in 2019

Figure 64. Europe General Anesthesia Drugs Value Market Share by Countries in 2019

Figure 65. Europe General Anesthesia Drugs Consumption Market Share by Type in 2019

Figure 66. Europe General Anesthesia Drugs Consumption Market Share by Application in 2019

Figure 67. Germany General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 68. Germany General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 69. France General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 70. France General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 71. UK General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 72. UK General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 73. Italy General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 74. Italy General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 75. Russia General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 76. Russia General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 77. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Countries in 2019

Figure 78. Middle East & Africa General Anesthesia Drugs Value Market Share by Countries in 2019

Figure 79. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Type in 2019

Figure 80. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Application in 2019

Figure 81. Egypt General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 82. Egypt General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 83. South Africa General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 84. South Africa General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 85. Israel General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 86. Israel General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 87. Turkey General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 88. Turkey General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 89. GCC Countries General Anesthesia Drugs Consumption Growth 2015-2020 (K L)

Figure 90. GCC Countries General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)

Figure 91. Global General Anesthesia Drugs Consumption Growth Rate Forecast (2021-2025) (K L)

Figure 92. Global General Anesthesia Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 93. Americas General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 94. Americas General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 95. APAC General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 96. APAC General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 97. Europe General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 98. Europe General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 99. Middle East & Africa General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 100. Middle East & Africa General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 101. United States General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 102. United States General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 103. Canada General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 104. Canada General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 105. Mexico General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 106. Mexico General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 107. Brazil General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 108. Brazil General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 109. China General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 110. China General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 111. Japan General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 112. Japan General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 113. Korea General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 114. Korea General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 115. Southeast Asia General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 116. Southeast Asia General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 117. India General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 118. India General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 119. Australia General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 120. Australia General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 121. Germany General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 122. Germany General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 123. France General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 124. France General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 125. UK General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 126. UK General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 127. Italy General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 128. Italy General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 129. Russia General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 130. Russia General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 131. Spain General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 132. Spain General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 133. Egypt General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 134. Egypt General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 135. South Africa General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 136. South Africa General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 137. Israel General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 138. Israel General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 139. Turkey General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 140. Turkey General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 141. GCC Countries General Anesthesia Drugs Consumption 2021-2025 (K L)

Figure 142. GCC Countries General Anesthesia Drugs Value 2021-2025 ($ Millions)

Figure 143. Astrazeneca General Anesthesia Drugs Market Share (2018-2020)

Figure 144. Nhwa General Anesthesia Drugs Market Share (2018-2020)

Figure 145. Fresenius-Kabi General Anesthesia Drugs Market Share (2018-2020)

Figure 146. Baxter Healthcare General Anesthesia Drugs Market Share (2018-2020)

Figure 147. B.Braun General Anesthesia Drugs Market Share (2018-2020)

Figure 148. AbbVie General Anesthesia Drugs Market Share (2018-2020)

Figure 149. Hikma Pharmaceuticals General Anesthesia Drugs Market Share (2018-2020)

Figure 150. Maruishi General Anesthesia Drugs Market Share (2018-2020)

Figure 151. Mylan General Anesthesia Drugs Market Share (2018-2020)

Figure 152. Piramal General Anesthesia Drugs Market Share (2018-2020)

Figure 153. Hengrui General Anesthesia Drugs Market Share (2018-2020)

Figure 154. Lunan General Anesthesia Drugs Market Share (2018-2020)